In 2015, Tomomi (56) reported that the overexpression of miR-145 can inhibit the expression of syndecan-1 and induce abnormally high SOX2 expression in BC cells, thereby inducing BC cell differentiation. This evidence concerns the gene SDC1 and breast cancer.